RBC Capital Markets advice for Vertex Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| April 30, 2018 | RBC Capital Markets | Vertex Pharma | Buy | 202.00 USD | 14.92 % |
Advice details
Toronto - Op 30 apr herhalen de analisten van RBC Capital Markets hun koopadvies voor Vertex Pharma (ISIN: US92532F1003 / Mnemo: VRTX). Het 12-maands koersdoel wordt opwaarts bijgesteld van 175.0 USD naar 202.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 